{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreieauwfvjrsjk5w4qykvsuz4vcw7km7d7rohra3p3gpys6qv7tzkbm",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mo2gcn7a4p22"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihs4yniv5gslv4xxwpwazmdqvpsj3sble4olz6hvbzdguafle3ihy"
    },
    "mimeType": "image/jpeg",
    "size": 123080
  },
  "path": "/pharmalot/2026/06/11/employer-overage-of-obesity-drugs-another-sanofi-setback/?utm_campaign=rss",
  "publishedAt": "2026-06-11T13:21:55.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharma",
    "Pharmalot",
    "pharmalittle",
    "STAT+"
  ],
  "textContent": "More employers are planning to drop coverage of GLP-1 drugs for weight loss next year as increasing numbers of people take the medications",
  "title": "STAT+: Pharmalittle: We’re reading about employer coverage of obesity drugs, another Sanofi setback, and more",
  "updatedAt": "2026-06-11T13:22:00.000Z"
}